NCT06976892 2025-08-13
IDOL
Institute of Cancer Research, United Kingdom
Phase 1 Recruiting
Clinical Trials
4 trialsNCT05976555 2025-06-11
Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma
Medical College of Wisconsin
Phase 1 Not yet recruiting
NCT02994953 2024-09-20
COMBO
EMD Serono
Phase 1 Terminated
NCT01647711 2017-01-31
A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations
Boehringer Ingelheim
Phase 1 Completed